Evidence map›Paper›PMID 30149120›Full record

ArticleClinical immunology (Orlando, Fla.)2018

Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90.

Maurer Kelly, Shi Lihua, Zhang Zhe, Song Li, Paucar Yoselin, Petri Michelle, E Sullivan Kathleen

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Targeting proteostasis pathways for cancer therapy.Journal of pharmaceutical analysis · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maurer KellyDivision of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Shi LihuaDivision of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Zhang ZheThe Center for Biomedical Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Song LiDivision of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Paucar YoselinDivision of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Petri MichelleDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.
E Sullivan KathleenDivision of Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States. Electronic address: sullivank@email.chop.edu.
Children's Hospital of Philadelphia · USJohns Hopkins Medicine · US

Funding

Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
Hopkins Lupus CohortR01AR069572 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 2016 to 2020
$3.4M
Epigenomics of SLER01AR058547 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI SULLIVAN, KATHLEEN E · 2009 to 2013
$1.8M
NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR058547NIAMS NIH HHS R01 AR069572
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) represents an autoimmune disease in which activation of the type I interferon pathway leads to dysregulation of tolerance and the generation of autoantibodies directed against nuclear constituents. The mechanisms driving the activation of the interferon pathway in SLE have been the subject of intense investigation but are still incompletely understood. Transposable elements represent an enormous source of RNA that could potentially stimulate the cell intrinsic RNA-recognition pathway, leading to upregulation of interferons. We used RNA-seq to define transposable element families and subfamilies in three cell types in SLE and found diverse effects on transposable element expression in the three cell types and even within a given family of transposable elements. When potential mechanisms were examined, we found that Hsp90 inhibition could drive increased expression of multiple type of transposable elements. Both direct inhibition and the delivery of a heat shock itself, which redirects heat shock regulators (including Hsp90) off of basal expression promoters and onto heat shock-responsive promoters, led to increased transposable element expression. This effect was amplified by the concurrent delivery of a histone deacetylase inhibitor. We conclude that transposable elements are dysregulated in SLE and there are tissue-specific effects and locus-specific effects. The magnitude of RNAs attributable to transposable elements makes their dysregulation of critical interest in SLE where transposable element RNA complexed with proteins has been shown to drive interferon expression.

Indexed as

B-LymphocytesCase-Control StudiesDNA Transposable ElementsFemaleHistone Deacetylase InhibitorsHistonesHSP90 Heat-Shock ProteinsHumansImmunologic FactorsInterferon-alphaInterferon-betaInterferon InducersLong Interspersed Nucleotide ElementsLupus Erythematosus, SystemicMonocytesPoly I-CDNA Transposable ElementsHistone Deacetylase InhibitorsHistonesHSP90 Heat-Shock ProteinsImmunologic FactorsInterferon-alphaInterferon-betaInterferon InducersPoly I-CAdarEpigeneticsHeat shockHistone deacetylase inhibitorLupusRNaseL

Identifiers

PMID30149120
PMCPMC6258342
OpenAlexW2888297430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.